| Item Type | Name |
|
Concept
|
Adolescent Behavior
|
|
Concept
|
Adolescent
|
|
Academic Article
|
Variants of the dopamine D2 receptor gene and risperidone-induced hyperprolactinemia in children and adolescents.
|
|
Academic Article
|
Weight gain and metabolic abnormalities during extended risperidone treatment in children and adolescents.
|
|
Academic Article
|
Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.
|
|
Academic Article
|
Predictors of risperidone and 9-hydroxyrisperidone serum concentration in children and adolescents.
|
|
Academic Article
|
Possible mechanisms for the skeletal effects of antipsychotics in children and adolescents.
|
|
Academic Article
|
Correlates of weight gain during long-term risperidone treatment in children and adolescents.
|
|
Academic Article
|
Iron deficiency in pediatric patients in long-term risperidone treatment.
|
|
Academic Article
|
Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.
|
|
Academic Article
|
Rate of weight gain and cardiometabolic abnormalities in children and adolescents.
|
|
Academic Article
|
Prolactin serum concentrations during aripiprazole treatment in youth.
|
|
Academic Article
|
Serum ferritin and amphetamine response in youth with attention-deficit/hyperactivity disorder.
|
|
Academic Article
|
Major depressive disorder and bone mass in adolescents and young adults.
|
|
Academic Article
|
Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment.
|
|
Academic Article
|
An open-label trial of aripiprazole in the treatment of aggression in male adolescents diagnosed with conduct disorder.
|
|
Academic Article
|
Fluoxetine for depression relapse prevention.
|
|
Academic Article
|
A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.
|
|
Academic Article
|
759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment.
|
|
Academic Article
|
The effect of psychostimulants on skeletal health in boys co-treated with risperidone.
|
|
Academic Article
|
Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys.
|
|
Academic Article
|
Iron homeostasis during risperidone treatment in children and adolescents.
|
|
Academic Article
|
Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children.
|
|
Academic Article
|
Fat distribution and major depressive disorder in late adolescence.
|
|
Academic Article
|
Serum Ferritin, Weight Gain, Disruptive Behavior, and Extrapyramidal Symptoms in Risperidone-Treated Youth.
|
|
Academic Article
|
Sexual Functioning in Adolescents With Major Depressive Disorder.
|
|
Academic Article
|
Toxoplasmosis Titers and past Suicide Attempts Among Older Adolescents Initiating SSRI Treatment.
|
|
Academic Article
|
Comorbidity of Migraine, Major Depressive Disorder, and Generalized Anxiety Disorder in Adolescents and Young Adults.
|
|
Academic Article
|
Bone Mass in Boys with Autism Spectrum Disorder.
|
|
Academic Article
|
Polyunsaturated fatty acid composition and childhood adversity: Independent correlates of depressive symptom persistence.
|
|
Academic Article
|
The Effect of Depression, Generalized Anxiety, and Selective Serotonin Reuptake Inhibitors on Change in Bone Metabolism in Adolescents and Emerging Adults.
|
|
Academic Article
|
CHRNA7 Deletions are Enriched in Risperidone-Treated Children and Adolescents.
|
|
Academic Article
|
Body Composition in Adolescents During Treatment With Selective Serotonin Reuptake Inhibitors.
|
|
Academic Article
|
Calcium and Vitamin D Supplementation in Boys with Risperidone-Induced Hyperprolactinemia: A Randomized, Placebo-Controlled Pilot Study.
|
|
Academic Article
|
Selective Serotonin Reuptake Inhibitors Reduce Longitudinal Growth in Risperidone-Treated Boys.
|
|
Academic Article
|
CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders.
|
|
Academic Article
|
Gut permeability and depressive symptom severity in unmedicated adolescents.
|
|
Grant
|
Long-Term Safety and Genetic Risk Factors of Risperdone Treatment in Youth
|
|
Grant
|
Serotonin Reuptake Inhibitors and Bone Mineralization in Adolescents
|
|
Grant
|
Examining SSRI-Induced Disruption of Pubertal Growth Spurt
|
|
Grant
|
Counteracting Risperidone-Induced Hyperprolactinemia in Youths
|
|
Academic Article
|
Predictors of depressive symptom trajectories in a prospective follow-up of late adolescents.
|
|
Academic Article
|
Experiential Avoidance Predicts Persistence of Major Depressive Disorder and Generalized Anxiety Disorder in Late Adolescence.
|
|
Grant
|
Examining the Skeletal Effects of Psychostimulants
|
|
Grant
|
Iron Deficiency and Brain Development in Youth with Internalizing Disorders
|
|
Academic Article
|
Inflammatory Markers Profile in Older Adolescents During Treatment with Selective Serotonin Reuptake Inhibitors.
|
|
Academic Article
|
Gut microbiome in adolescent depression.
|
|
Grant
|
Body Iron and Mental Health-Related Outcomes in Adolescents: A NHANES Data Analysis
|
|
Academic Article
|
Sexual Functioning in Adolescents With Major Depressive Disorder: A Prospective Study.
|
|
Academic Article
|
Iron deficiency and internalizing symptom severity in unmedicated adolescents: a pilot study.
|
|
Academic Article
|
Psychological and Psychiatric Comorbidities in Youth with Serious Physical Illness.
|
|
Academic Article
|
Extraskeletal calcifications in a dialysis-dependent teenager: A novel cause of acquired pediatric complete heart block.
|
|
Academic Article
|
Iron Deficiency in Attention-Deficit Hyperactivity Disorder, Autism Spectrum Disorder, Internalizing and Externalizing Disorders, and Movement Disorders.
|
|
Academic Article
|
Utilization and Predictors of Adjuvant Metformin for Children and Adolescents on Mixed Receptor Antagonists (Second-Generation Antipsychotics).
|
|
Academic Article
|
Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescents.
|
|
Academic Article
|
Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation Antipsychotics.
|
|
Academic Article
|
Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults.
|
|
Academic Article
|
Adherence to Recommended Metabolic Monitoring of Children and Adolescents Taking Second-Generation Antipsychotics.
|
|
Academic Article
|
The Effectiveness of Metformin in Managing Second Generation Antipsychotic-Induced Weight Gain in Children and Adolescents.
|